We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.82B
AUM Growth
-$248M
Cap. Flow
-$261M
Cap. Flow %
-14.34%
Top 10 Hldgs %
41.42%
Holding
163
New
45
Increased
20
Reduced
35
Closed
58

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.7M
2
ADNT icon
Adient
ADNT
+$39.7M
3
CMA
Comerica
CMA
+$39.6M
4
SBGI icon
Sinclair Inc
SBGI
+$39.5M
5
META icon
Meta Platforms (Facebook)
META
+$32M

Top Sells

Rank Stock Value
1
IP icon
International Paper
IP
+$65.7M
2
UNP icon
Union Pacific
UNP
+$65.6M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$60.3M
4
APA icon
APA Corp
APA
+$30.7M
5
LNC icon
Lincoln National
LNC
+$30.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.18%
2 Communication Services 10.85%
3 Consumer Staples 8.78%
4 Financials 8.32%
5 Consumer Discretionary 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLX icon
76
Clorox
CLX
$11.6B
$3.99M 0.22%
+29,561
New +$3.83M
PTCT icon
77
CALL
PTC Therapeutics
PTCT
$5.68B
$3.96M 0.22%
402,800
+202,800
+101% +$2.45M
HSY icon
78
Hershey
HSY
$35.2B
$3.71M 0.2%
+33,929
New +$3.64M
LUMO
79
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.62M 0.2%
+16,667
New +$2.38M
AHL
80
DELISTED
ASPEN Insurance Holding Limited
AHL
$3.38M 0.19%
+64,914
New +$3.6M
PTCT icon
81
PTC Therapeutics
PTCT
$5.68B
$2.81M 0.15%
285,284
-319,716
-53% -$3.87M
WIN
82
DELISTED
Windstream Holdings Inc
WIN
$2.73M 0.15%
+100,000
New +$3.57M
SCTL
83
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2.72M 0.15%
346,434
-411
-0.1% -$2.86K
CYH icon
84
Community Health Systems
CYH
$393M
$2.66M 0.15%
+300,000
New +$2.34M
ULTA icon
85
Ulta Beauty
ULTA
$22B
$2.56M 0.14%
8,966
-18,034
-67% -$4.94M
LUMO
86
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.41M 0.13%
+11,111
New +$1.59M
AZO icon
87
AutoZone
AZO
$49.2B
$1.99M 0.11%
+2,750
New +$2.04M
PTLA
88
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.96M 0.11%
+50,000
New +$1.59M
PRTK
89
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.93M 0.11%
+100,000
New +$1.58M
INFY icon
90
PUT
Infosys
INFY
$48.7B
$1.74M 0.1%
+220,000
New +$1.64M
EAT icon
91
Brinker International
EAT
$9.17B
$1.65M 0.09%
37,500
-22,500
-38% -$996K
AZN icon
92
CALL
AstraZeneca
AZN
$263B
$1.56M 0.09%
25,000
-125,850
-83% -$7.33M
FLXN
93
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.49M 0.08%
+55,500
New +$1.13M
JAGX icon
94
Jaguar Health
JAGX
$4.91M
– –
0
– –
RDY icon
95
PUT
Dr. Reddy's Laboratories
RDY
$9.87B
$923K 0.05%
+115,000
New +$993K
CBOE icon
96
Cboe Global Markets
CBOE
$32.5B
$774K 0.04%
+9,550
New +$747K
TWNK
97
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$597K 0.03%
+37,600
New +$562K
AAL icon
98
American Airlines Group
AAL
$10.1B
$563K 0.03%
450,000
-365,000
-45% -$16.5M
ARCT icon
99
Arcturus Therapeutics
ARCT
$164M
$401K 0.02%
50,203
-42,654
-46% -$395K
TNXP icon
100
Tonix Pharmaceuticals
TNXP
$160M
– –
0
– –
2 3
4
5 6

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Kingdon Capital Management held 163 positions worth $1.82B, down 12% from $2.07B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kingdon Capital Management withdrew a net $261M in Q1 2017, closing 58 positions and reducing 35 holdings. Its most notable exit was International Paper, an estimated $65.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Kingdon Capital Management opened a new position in Comerica worth $38.9M.

  • Kingdon Capital Management's largest Q1 2017 buy was Comerica: 567,838 shares worth $38.9M.
  • Kingdon Capital Management added most to DuPont de Nemours in Q1 2017, an estimated $44.7M increase.
  • Kingdon Capital Management's biggest Q1 2017 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $60.3M.
  • Kingdon Capital Management fully exited International Paper in Q1 2017, selling an estimated $65.7M.
  • Kingdon Capital Management's ten largest holdings make up 41% of its $1.82B portfolio in Q1 2017.
  • Kingdon Capital Management opened 45 new positions and closed 58 in Q1 2017.
  • Kingdon Capital Management's portfolio value fell 12% quarter-over-quarter to $1.82B.

Based on Kingdon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.